Plaque Type PsorisisPhase 2NCT07410793
Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
A Phase 2 study testing Acupuncture, Calcipotriol 0.005% ointment and Chinese herb cream in people with Plaque Type Psorisis, run by Mae Fah Luang University at 1 site in Thailand.
Trial summary
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Plaque Type Psorisis
- What is being tested?
- Acupuncture, Calcipotriol 0.005% ointment and Chinese herb cream
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteThailand
- Study dates
- 9 Feb 2026to 8 Feb 2027
- Phase
- Phase 2
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Plaque psoriasis on skin, scalp, or nails
- Not receive any psoriasis treatment at least 4 weeks prior to the study
- ≤10% body surface area (BSA), PASI≤10, DLQI≤10
Who cannot join
- Pregnancy and lactation
- Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis
- Uncontrollable diseases i.e. CVS, liver, kidney, cancer
- Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin
- Treated with psoriasis biologic agents in the past 6 months
- Needle phobia
- Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents
- Participating in other clinical study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Asst.Prof.Dr.Chakree Chumvisoot Wattanasiri, RPh, PhD contact
Thailand1 site, 1 recruiting
- Recruiting
Mae Fah Luang University
Muang, Chiangrai, 57100
Dr.Sinee Tantasatityanon, TCMD, PhD, +6618092078, sinee.tan@mfu.ac.th
About this study
Official title: Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis.
- Conditions
- Plaque Type Psorisis
- Being tested
- Acupuncture, Calcipotriol 0.005% ointment, Chinese herb cream
- Keywords
- plaque psoriasis, acupuncture, chinese herbal cream, calcipotriol
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AcupunctureProcedure or surgery
Bai-Hui (GV20), Fei-Shu (BL13), Ge-Shu (BL-17), Qu-Chi (LI11), Zu-San-Li (ST36), He-Gu (LI4), Tai-Chong (LR3), San-Yin-Jiao (SP6), Wei-Zhong (BL40)
Calcipotriol 0.005% ointmentDrug
Calcipotriol 0.005% ointment
Chinese herb creamDrug
Main API : Sophora flavescens Ait. (Ku-Shen), Cnidium monnieri (L.) Cuss. (She-Chuang-Zi), Prunus mume (Sieb.) Sieb.et Zucc. (Wu-Mei), Dictamnus dasycarpus Turcz. (Bai-Xian-Pi), Rheum palmatum L. (Da-Huang)
| Study group | Role | What they receive |
|---|---|---|
| Acupucture + Calcipotriol | Active comparator | Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Calcipotriol cream. Receives: Procedure: Acupuncture; Drug: Calcipotriol 0.005% ointment |
| Acupuncture + Chinese Herbal Cream | Experimental | Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Chinese Herbal cream. Receives: Procedure: Acupuncture; Drug: Chinese herb cream |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psoriasis Area and Severity Index, PASI score
Measured: 8 weeks
Secondary outcomes (1)
Dermatology Life Quality Index (DLQI)
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2026
- Study start9 Feb 2026
- Primary completion8 Feb 2027 (estimated)
- Study completion8 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Plaque Type PsorisisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 28 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mae Fah Luang University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07410793
- Sponsor's protocol ID
- EC 25228-25
- Status last verified
- Feb 2026
- First submitted
- 8 Feb 2026
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
- ClinicalTrials.gov ID
- NCT07410793
- Acronym / sponsor ID
- EC 25228-25
- Conditions
- Plaque Type Psorisis
- Keywords
- plaque psoriasis, acupuncture, chinese herbal cream, calcipotriol
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 28 participants (estimated)
- Lead sponsor
- Mae Fah Luang UniversityUniversity, hospital or other
- Study start
- 9 Feb 2026 (actual)
- Primary completion
- 8 Feb 2027 (estimated)
- Study completion
- 8 Feb 2027 (estimated)
- First posted
- 13 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Acupucture + Calcipotriol | Active comparator | Procedure: Acupuncture, Drug: Calcipotriol 0.005% ointmentParticipant will receive 1 Acupuncture session per week for 8 weeks. And also receive Calcipotriol cream. |
| Acupuncture + Chinese Herbal Cream | Experimental | Procedure: Acupuncture, Drug: Chinese herb creamParticipant will receive 1 Acupuncture session per week for 8 weeks. And also receive Chinese Herbal cream. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Plaque psoriasis on skin, scalp, or nails
- Not receive any psoriasis treatment at least 4 weeks prior to the study
- ≤10% body surface area (BSA), PASI≤10, DLQI≤10
Key exclusion criteria (8 listed)
- Pregnancy and lactation
- Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis
- Uncontrollable diseases i.e. CVS, liver, kidney, cancer
- Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin
- Treated with psoriasis biologic agents in the past 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AcupunctureBai-Hui (GV20), Fei-Shu (BL13), Ge-Shu (BL-17), Qu-Chi (LI11), Zu-San-Li (ST36), He-Gu (LI4), Tai-Chong (LR3), San-Yin-Jiao (SP6), Wei-Zhong (BL40) | Procedure or surgery | Acupucture + Calcipotriol, Acupuncture + Chinese Herbal Cream |
| Calcipotriol 0.005% ointmentCalcipotriol 0.005% ointment | Drug | Acupucture + Calcipotriol |
| Chinese herb creamMain API : Sophora flavescens Ait. (Ku-Shen), Cnidium monnieri (L.) Cuss. (She-Chuang-Zi), Prunus mume (Sieb.) Sieb.et Zucc. (Wu-Mei), Dictamnus dasycarpus Turcz. (Bai-Xian-Pi), Rheum palmatum L. (Da-Huang) | Drug | Acupuncture + Chinese Herbal Cream |
Primary outcome
Psoriasis Area and Severity Index, PASI score
Time frame: 8 weeks
1 secondary outcome
Dermatology Life Quality Index (DLQI)
Time frame: 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Plaque Type Psorisis
Recruiting
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Plaque Type Psorisis, Non-pustular Palmoplantar Psoriasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Asst.Prof.Dr.Chakree Chumvisoot Wattanasiri, RPh, PhD contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Acupuncture, Calcipotriol 0.005% ointment and Chinese herb cream in people with Plaque Type Psorisis, run by Mae Fah Luang University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dr.Sinee Tantasatityanon, TCMD, PhD (+66818092078, sinee.tan@mfu.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psoriasis Area and Severity Index, PASI score (time frame: 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.